Modulation of Multidrug Resistance Protein 2 Efflux in the Cisplatin Resistance Human Ovarian Carcinoma Cells A2780/RCIS by Sesquiterpene Coumarins

Phytotherapy Research

Volumn 30, Issue 1, 2016, Pages 84-89

  Kasaian, Jamal ^a   Mosaffa, Fatemeh ^a   Behravan, Javad ^a   Masullo, Milena ^b   Piacente, Sonia ^b   Iranshahi, Mehrdad ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF SALERNO   (Italy)

Author keywords

Apiaceae; Ferula flabelliloba; Ferula galbaniflua; Ferula gummosa; Ferula szowitsiana; multidrug resistance protein 2; ovarian carcinoma

Indexed keywords

5-CARBOXYFLUORESCEIN DIACETATE; ANTINEOPLASTIC AGENT; CISPLATIN; COUMARIN DERIVATIVE; FARNESIFEROL A; FARNESIFEROL B; FARNESIFEROL C; FLUORESCEIN DERIVATIVE; MOGOLTACIN; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 2; SESQUITERPENE;

CHEMISTRY; DRUG EFFECTS; DRUG RESISTANCE; FEMALE; FERULA; HUMAN; METABOLISM; MULTIDRUG RESISTANCE; OVARY TUMOR; PATHOLOGY; PLANT ROOT; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; CISPLATIN; COUMARINS; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FEMALE; FERULA; FLUORESCEINS; HUMANS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; OVARIAN NEOPLASMS; PLANT ROOTS; SESQUITERPENES;

EID: 84954051224     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.5504     Document Type: Article

References (29)

1. Behnam Rassouli F, Matin MM, Iranshahi M, et al., 2009. Mogoltacin enhances vincristine cytotoxicity in human transitional cell carcinoma (TCC) cell line. Phytomedicine 16: 181-187.
2. Coburger C, Wollmann J, Krug M, et al., 2010. Novel structure-activity relationships and selectivity profiling of cage dimeric 1,4-dihydropyridines as multidrug resistance (MDR) modulators. Bioorg Med Chem 18: 4983-4990.
3. Deng J, Shao J, Markowitz JS, An G,. 2014. ABC transporters in multidrug resistance and ADME-Tox of small molecule tyrosine kinase inhibitors. Pharm Res 31: 2237-2255.
4. Esmail Nazari Z, Iranshahi M,. 2011. Biologically active sesquiterpene coumarins from Ferula species. Phytother Res 25: 315-323.
5. Hanafi-Bojd MY, Iranshahi M, Mosaffa F, Tehrani SO, Kalalinia F, Behravan J,. 2011. Farnesiferol A from Ferula persica and galbanic acid from Ferula szowitsiana inhibit P-glycoprotein-mediated rhodamine efflux in breast cancer cell lines. Planta Med 77: 1590-1593.
6. Hlavata I, Mohelnikova-Duchonova B, Vaclavikova R, et al., 2012. The role of ABC transporters in progression and clinical outcome of colorectal cancer. Mutagenesis 27: 187-196.
7. Iranshahi M,. 2012. A review of volatile sulfur-containing compounds from terrestrial plants: biosynthesis, distribution and analytical methods. J Essent Oil Res 24: 393-434.
8. Iranshahi M, Amin GR, Amini M, Shafiee A,. 2003a. Sulfur containing derivatives from Ferula persica var. latisecta. Phytochemistry 63: 965-966.
9. Iranshahi M, Amin GR, Jalalizadeh H, Shafiee A,. 2003b. New germacrane derivative from Ferula persica Willd. var. latisecta Chamberlain. Pharm Biol 41: 431-433.
10. Iranshahi M, Amin G, Shafiee A,. 2004. A new coumarin from Ferula persica. Pharm Biol 42: 440-442.
11. Iranshahi M, Amin G, Sourmaghi MS, Shafiee A, Hadjiakhoondi A,. 2006. Sulphur containing compounds in the essential oil of Ferula persica Willd. var. persica. Flavour Fragrance J 21: 260-261.
12. Iranshahi M, Hosseini ST, Shahverdi AR, Molazade K, Khan SS, Ahmad VU,. 2008. Diversolides A-G, guaianolides from the roots of Ferula diversivittata. Phytochemistry 69: 2753-2757.
13. Iranshahi M, Kalategi F, Sahebkar A, Sardashti A, Schneider B,. 2010a. New sesquiterpene coumarins from the roots of Ferula flabelliloba. Pharm Biol 48: 217-220.
14. Iranshahi M, Masullo M, Asili A, et al., 2010b. Sesquiterpene coumarins from Ferula gumosa. J Nat Prod 73: 1958-1962.
15. Iranshahi M, Barthomeuf C, Bayet-Robert M, et al., 2014. Drimane-type sesquiterpene coumarins from Ferula gummosa fruits enhance doxorubicin uptake in doxorubicin-resistant human breast cancer cell line. J Tradit Complementary Med 4: 118-125.
16. Kasaian J, Iranshahy M, Iranshahi M,. 2014a. Synthesis, biosynthesis and biological activities of galbanic acid. Pharm Biol 52: 524-531.
17. Kasaian J, Iranshahy M, Masullo M, Piacente S, Ebrahimi F, Iranshahi M,. 2014b. Sesquiterpene lactones from Ferula oopoda and their cytotoxic properties. J Asian Nat Prod Res 16: 248-253.
18. Kasaian J, Mosaffa F, Behravan J, et al., 2015. Reversal of P-glycoprotein-mediated multidrug resistance in MCF-7/Adr cancer cells by sesquiterpene coumarins. Fitoterapia 103: 149-154.
19. Kowalski P, Surowiak P, Lage H,. 2005. Reversal of different drug-resistant phenotypes by an autocatalytic multitarget multiribozyme directed against the transcripts of the ABC transporters MDR1/P-gp, MRP2, and BCRP. Mol Ther 11: 508-522.
20. Lee G, Piquette-Miller M,. 2001. Influence of IL-6 on MDR and MRP-mediated multidrug resistance in human hepatoma cells. Can J Physiol Pharmacol 79: 876-884.
21. Madureira AM, Molnár A, Abreu PM, Molnár J, Ferreira MJ,. 2004. A new sesquiterpene-coumarin ether and a new abietane diterpene and their effects as inhibitors of P-glycoprotein. Planta Med 70: 828-833.
22. Mozaffarian V,. 1996. A dictionary of Iranian plant names. Farhang-e Moaser: Tehran; 228-230.
23. Neshati V, Matin MM, Iranshahi M, et al., 2009. Cytotoxicity of vincristine on the 5637 cell line is enhanced by combination with conferone. Z Naturforsch C 64: 317-322.
24. Rassouli FB, Matin MM, Iranshahi M, et al., 2011. Investigating the enhancement of cisplatin cytotoxicity on 5637 cells by combination with mogoltacin. Toxicol in Vitro 25: 469-474.
25. Sekine T, Miyazaki H, Endou H,. 2006. Molecular physiology of renal organic anion transporters. Am J Physiol Renal Physiol 290: 251-261.
26. Suberu JO, Romeo-Canelon I, Sullivan N, Lapkin AA, Barker GC,. 2014. Comparative cytotoxicity of artemisinin and cisplatin and their interactions with chlorogenic acids in MCF7 breast cancer cells. ChemMedChem 9: 2791-2797.
27. Taniguchi K, Wada M, Kohno K, et al., 1996. A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation. Cancer Res 56: 4124-4129.
28. Tiwari AK, Sodani K, Dai CL, Ashby CR Jr, Chen ZS,. 2011. Revisiting the ABCs of multidrug resistance in cancer chemotherapy. Curr Pharm Biotechnol 12: 570-594.
29. Van Kuijck MA, Kool M, Merkx GF, et al., 1997. Assignment of the canalicular multispecific organic anion transporter gene (CMOAT) to human chromosome 10q24 and mouse chromosome 19D2 by fluorescent in situ hybridization. Cytogenet Cell Genet 77: 285-287.